论文部分内容阅读
AIM To provide evidence regarding the postoperative treatment of patients with T4bN1-3M0/TxN3bM0 gastric cancer,for which guidelines have not been established.METHODS Patients who had undergone curative resection between 1996 and 2014 with a pathological